UK Vaping Association Calls for Stricter Regulations

Mar.23.2023
UK Vaping Association Calls for Stricter Regulations
The UK electronic cigarette industry faces a "glaring failure" as ELFBAR and Lost Mary products are recalled due to exceeding standard nicotine levels.

On March 22nd, the Electronic Cigarette Association of the UK announced that the withdrawal of ELFBAR and Lost Mary products with nicotine levels exceeding the legal limit demonstrated a "glaring failure" in the UK's electronic cigarette regulation framework.


John Dunne, the director general of UK Vaping Industry Association (UKVIA), has stated that it is now clear that approving e-cigarette products without compliance testing is not feasible, whether before or after approval.


He made the statement following a joint announcement from the Medicines and Healthcare products Regulatory Agency (MHRA) and the Chartered Trading Standards Institute (CTSI) in the UK. The products recalled include ELFBAR and Lost Mary brands.


Deng En stated, 'Although we are aware that mistakes may occur, we must do everything possible to ensure they happen as little as possible. Because, as we have seen in recent weeks, the reputation of the entire industry depends on it.'


During the MHRA approval process, there should be a testing plan in place for random sampling to ensure that products not only meet requirements upon initial market entry, but also maintain these standards over time.


We still need to see authorities taking swift and decisive action upon uncovering any violations of the law, in order to quickly correct mistakes and make it clear to manufacturers, distributors and retailers what actions they need to take.


He said that from the issue of excessive e-liquid to the announcement that non-compliant products must be taken down, these controversies have caused widespread confusion within the industry and among consumers.


Deng En noted that in order to maintain public confidence in the industry, retailers, distributors, and manufacturers must be aware that any non-compliant behavior will be taken seriously.


He added: "The MHRA should seriously consider the ECID numbers of products found to be non-compliant and suspend their authorization until the issue has been truly resolved.


This also highlights the need for a universal standard for compliance testing (such as e-cigarette e-liquid).


The UKVIA has obtained the independent test results of electronic cigarette products. Concerningly, conflicting results have been observed depending on the type of test conducted.


A recent joint statement by CTSI and MHRA has stated that on February 23, they advised law enforcement officers that, in accordance with Regulation 39 of the Tobacco and Related Products Regulations (TRPRs), all non-compliant E-Liquid Flavourings, Additives and Response products must be removed from sale.


There has been further communication between ElLFBAR and MHRA to update the corrective action plan and identify more affected batches, including some of the Lost Mary products.


CTSI and MHRA are pleased to note that compliant alternative products have now arrived in the country. We continue to expect all manufacturers to act responsibly and will promptly share any further information received with enforcement officials.


The joint statement additionally states that:


There is no evidence to suggest that using the ELFBAR or LostMary products, which have been overfilled with e-juice, poses a greater health risk during normal use.


The vigilance required in Article 39 is specifically applicable to non-compliant and unsafe products.


Products that do not meet requirements are not permitted to be sold to consumers.


If batches of products that do not meet requirements are still on the shelves, whether action should be taken is determined by the priorities, competitive demands, and available resources in the local area.


It said the affected batches are as follows:


Previous notice:


ELFBAR 600s with the following batch numbers: ep0i7693, ep020398, ep020250, ep019749, ep020257, ep019746, ep020120, ep020394, ep019893, ep019894.


Other Batches:


MaryBM600 has gone missing.


Taste: Watermelon, apple, kiwi, passionfruit, pomegranate, cotton candy ice cream, strawberry ice cream, blueberry sour raspberry.


Batch Numbers: LP017641, LP018253, LP019438, LP019923, LP020487, LP021149.


Mary QM600 has gone missing.


Taste: Grape and Cola.


Batch: LP017906 and LP016850.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
From Vuse, Velo and glo to AI Consulting: Former BAT Content Lead Launches Destreza
Former BAT global content lead Andy Parton has left the company and launched Destreza, a London-based AI-native marketing consultancy. Parton previously worked across BAT's New Category brands Vuse, Velo and glo and had also served as Global Brand Lead for Vuse Go. Destreza says it will advise consumer businesses on AI in brand strategy, operating models, capability and agency configuration, using specialist AI agents to support research, strategy and creative development. BAT reported £3.621 billion in New Category revenue in 2025.
Sep.22
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
PMI's IQOS Extends ZAMNA Electronic-Music Partnership to Spain as Vogue España Publishes Branded Content
Philip Morris International's IQOS has extended its partnership with electronic-music event brand ZAMNA to Spain, setting up a House of IQOS at ZAMNA Madrid. Vogue España and Time Out Madrid subsequently published branded content clearly labeled as collaborations with IQOS. PMI has also expanded its company-owned IQOS boutique network in Spain to seven cities this year. The company says IQOS's adjusted heated-tobacco market share in Europe reached 12.6% in the first quarter of 2026, with Spain among its stronger-performing European markets.
Sep.20
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
Philip Morris International’s IQOS has entered the Kantar BrandZ Top 100 Most Valuable Global Brands for the first time, ranking No. 74 with a brand value of $36.634 billion and becoming one of only three newcomers to the 2026 ranking. Kantar said the combined value of the Global Top 100 reached $13.1 trillion, up 22% year on year, while the threshold for entry rose to a record high. PMI says IQOS has more than 35 million users worldwide and surpassed $10 billion in annual net revenues within a decade of launch.
Sep.03